Scholars Central

Conference abstractPublished 8 Sep 2014

Sequence variations in recombinant therapeutic proteins

Authors: Chava Kimchi-Sarfaty

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The presentation will include our experience with coagulation-based recombinant proteins, specifically those recombinant proteins involving genetically engineered/optimized coding sequences. Recombinant therapeutics may prove advantageous over human-plasma-derived products due to decreased prion and viral contamination. The optimized and other unnatural sequences may have a significant impact on the expression, half-life, localization and physiologic function of these therapeutic proteins. The presentation will highlight possible effects of one or more synonymous or non-synonymous mutations on a broad spectrum of recombinant therapeutic proteins.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Molecular and Genetic Medicine.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMolecular and Genetic Medicine
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Chava Kimchi-Sarfaty”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels